文献速递泌尿生殖介入腹部CT

术中增强CT在肾脏肿物消融中的应用价值

Utility of Intraprocedural Contrast-Enhanced CT in Ablation of Renal Masses.
PubMed 文献 · AJR Am J Roentgenol · 2019-09-18

回顾性分析45例连续登记的肾脏肿物射频消融患者,其中32例术中行增强CT、13例未行。术中增强CT组原发技术有效率96%,未行组70%,总体技术有效率89%;两组技术有效率差异有统计学意义(p < 0.05)。作者认为术中增强CT可提供消融完整性的重要信息,便于调整电极位置,从而获得更好疗效。

要点

  • 术中增强CT组原发技术有效率96%,未行术中增强CT组70%,两组差异有统计学意义(p < 0.05)。
  • 术中增强CT可判断消融是否完全,并允许术中重新调整电极位置。
  • 本研究为回顾性连续病例分析,样本量45例,结论需结合原文局限性解读。

核心结论

  • 术中增强CT可提供消融完整性的重要信息,允许术中调整电极位置,从而获得更好的治疗效果。

研究设计与样本

  • 回顾性连续病例分析,纳入45例连续登记接受肾脏肿物射频消融的患者。
  • 射频消融使用两根冷头电极;术中增强CT组32例,未行术中增强CT组13例。
  • 若未取得足够活检标本或随访不充分,则将该患者从原发技术有效率计算中剔除;最终35例符合随访及活检阳性标准,其中未行术中增强CT组10例、行术中增强CT组25例。
  • 评估内容包括基线人口学资料(年龄、体重指数、性别)、肾脏肿物特征(直径、侧别、位置、体位、形态特征、肿物类型及分级)、技术细节(重新定位及水分离)和并发症;随访影像用于判断消融部位是否复发。

诊断标准与关键数值

  • 总体技术有效率为89%;术中增强CT组原发技术有效率为96%,未行术中增强CT组为70%(p < 0.05,原文表述为两组技术有效率呈负相关)。
  • 两组在基线人口学资料、肾脏肿物特征及技术结果方面均无相关性。

临床应用与阅片要点

  • 作者认为术中增强CT可提供消融完整性的重要信息,允许术中调整电极位置,从而获得更好的治疗效果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purpose of this study was to evaluate the efficacy of radiofrequency ablation (RFA) of renal masses comparing a group who did not undergo intraprocedural CT and a group who did. MATERIALS AND METHODS. A retrospective review included 45 consecutively registered patients who underwent RFA of renal masses. If an adequate biopsy specimen was not obtained or follow-up was inadequate, the patient was eliminated from review from calculation of primary technical efficacy. The inclusion criterion was having undergone RFA with two cooled-tip electrodes. Baseline demographics (age, body mass index, and sex), renal mass characteristics (diameter, side, location, position, morphologic features, type of mass, and grade), technical details (repositioning and hydrodissection), and complications were evaluated. Follow-up images were evaluated to determine the presence of recurrence at the ablation site in the two groups. RESULTS. Among the 45 patients who underwent RFA, 13 did not undergo intraprocedural CT and 32 intraprocedural did. Thirty-five patients met the criteria for follow-up and positive biopsy results. For calculation of recurrence, 10 patients were in the group who did not and 25 were in group who did undergo intraprocedural contrast-enhanced CT. No correlation was found between baseline demographics, renal mass characteristics, and technical results of the two groups. There was an 89% overall technical efficacy rate with a 96% primary technical efficacy rate in the group who underwent intraprocedural CT compared with a 70% rate in the group who did not undergo intraprocedural CT. Negative correlation was found between the groups with respect to technical efficacy rate at p < 0.05. CONCLUSION. Intraprocedural contrast-enhanced CT yields important information about completeness of ablation during the procedure, allowing probe repositioning and thus better therapeutic effect.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Grewal A, Khera SS, McGahan JP, et al. Utility of Intraprocedural Contrast-Enhanced CT in Ablation of Renal Masses. AJR Am J Roentgenol. 2019. PMID: 31532258. doi:10.2214/AJR.19.21584

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。